Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (Hylaform® from rooster combs and Restylane® from streptococcus) used for soft tissue augmentation

F. Manna, M. Dentini, P. Desideri, O. De Pità, E. Mortilla, B. Maras

Research output: Contribution to journalArticle

Abstract

Hyaluronic acid (HA) derivatives have been developed to try to enhance rheological properties of this molecule to make it suitable for various medical applications. The main dermatological application of HA derivatives is the augmentation of soft tissues, via injection into the dermis. HA derivatives are indicated for the correction of cutaneous contour deficiencies of the skin, particularly in cases of ageing or degenerative lesions or to increase lips. Two HA derivatives have been evaluated: Hylaform® Viscoelastic Gel (Hylan B), derived from rooster combs and subjected to cross-linking, and Restylane®, produced through bacterial fermentation (streptococci) and stabilized, as declared by the producer. In both cases the purpose is to improve HA rheological characteristics and slow down its degradation once it is in contact with biological structures. Distribution of particle dimensions, pH, protein concentration and rheological properties have been investigated in order to evaluate their reliability as fillers for soft tissue augmentation. The results of the analyses showed that there are differences between Restylane® and Hylaform®. Especially as far as rheological characteristics are concerned, the results outline different structures of the products: Hylaform® behaves as a strong hydrogel, Restylane® as a weak hydrogel; rheologically Hylaform® is clearly superior to Restylane®. Hylaform® contains a definitely minor quantity (about a quarter) of cross-linked hyaluronic acid than Restylane®. Furthermore, although not declared by the manufacturer, Restylane® contains protein, resulting from bacterial fermentation or added to enable cross-linking reaction; the quantity of proteins contained by Restylane® can be as much as four times the quantity contained by Hylaform®, for the same volume (1 ml). It is evident that Hylaform® offers higher safety margin than Restylane®. Furthermore, wide literature and 20 years of clinical experience on hyaluronan derived from rooster combs confirm the reliability of this derivative while we did not find evidence regarding about the safety of HA obtained from streptococcus.

Original languageEnglish
Pages (from-to)183-192
Number of pages10
JournalJournal of the European Academy of Dermatology and Venereology
Volume13
Issue number3
DOIs
Publication statusPublished - 1999

Fingerprint

Comb and Wattles
Hyaluronic Acid
Streptococcus
Hydrogel
Fermentation
Safety
Skin
Bacterial Proteins
hylan-B gel
Restylane
Cross Reactions
Dermis
Lip
Proteins
Injections

Keywords

  • Hyaluronic acid
  • Hylan B
  • Soft tissue augmentation

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Cite this

@article{25fdf39529184b0a97e9de5c3325917a,
title = "Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (Hylaform{\circledR} from rooster combs and Restylane{\circledR} from streptococcus) used for soft tissue augmentation",
abstract = "Hyaluronic acid (HA) derivatives have been developed to try to enhance rheological properties of this molecule to make it suitable for various medical applications. The main dermatological application of HA derivatives is the augmentation of soft tissues, via injection into the dermis. HA derivatives are indicated for the correction of cutaneous contour deficiencies of the skin, particularly in cases of ageing or degenerative lesions or to increase lips. Two HA derivatives have been evaluated: Hylaform{\circledR} Viscoelastic Gel (Hylan B), derived from rooster combs and subjected to cross-linking, and Restylane{\circledR}, produced through bacterial fermentation (streptococci) and stabilized, as declared by the producer. In both cases the purpose is to improve HA rheological characteristics and slow down its degradation once it is in contact with biological structures. Distribution of particle dimensions, pH, protein concentration and rheological properties have been investigated in order to evaluate their reliability as fillers for soft tissue augmentation. The results of the analyses showed that there are differences between Restylane{\circledR} and Hylaform{\circledR}. Especially as far as rheological characteristics are concerned, the results outline different structures of the products: Hylaform{\circledR} behaves as a strong hydrogel, Restylane{\circledR} as a weak hydrogel; rheologically Hylaform{\circledR} is clearly superior to Restylane{\circledR}. Hylaform{\circledR} contains a definitely minor quantity (about a quarter) of cross-linked hyaluronic acid than Restylane{\circledR}. Furthermore, although not declared by the manufacturer, Restylane{\circledR} contains protein, resulting from bacterial fermentation or added to enable cross-linking reaction; the quantity of proteins contained by Restylane{\circledR} can be as much as four times the quantity contained by Hylaform{\circledR}, for the same volume (1 ml). It is evident that Hylaform{\circledR} offers higher safety margin than Restylane{\circledR}. Furthermore, wide literature and 20 years of clinical experience on hyaluronan derived from rooster combs confirm the reliability of this derivative while we did not find evidence regarding about the safety of HA obtained from streptococcus.",
keywords = "Hyaluronic acid, Hylan B, Soft tissue augmentation",
author = "F. Manna and M. Dentini and P. Desideri and {De Pit{\`a}}, O. and E. Mortilla and B. Maras",
year = "1999",
doi = "10.1016/S0926-9959(99)00089-6",
language = "English",
volume = "13",
pages = "183--192",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "wiley",
number = "3",

}

TY - JOUR

T1 - Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (Hylaform® from rooster combs and Restylane® from streptococcus) used for soft tissue augmentation

AU - Manna, F.

AU - Dentini, M.

AU - Desideri, P.

AU - De Pità, O.

AU - Mortilla, E.

AU - Maras, B.

PY - 1999

Y1 - 1999

N2 - Hyaluronic acid (HA) derivatives have been developed to try to enhance rheological properties of this molecule to make it suitable for various medical applications. The main dermatological application of HA derivatives is the augmentation of soft tissues, via injection into the dermis. HA derivatives are indicated for the correction of cutaneous contour deficiencies of the skin, particularly in cases of ageing or degenerative lesions or to increase lips. Two HA derivatives have been evaluated: Hylaform® Viscoelastic Gel (Hylan B), derived from rooster combs and subjected to cross-linking, and Restylane®, produced through bacterial fermentation (streptococci) and stabilized, as declared by the producer. In both cases the purpose is to improve HA rheological characteristics and slow down its degradation once it is in contact with biological structures. Distribution of particle dimensions, pH, protein concentration and rheological properties have been investigated in order to evaluate their reliability as fillers for soft tissue augmentation. The results of the analyses showed that there are differences between Restylane® and Hylaform®. Especially as far as rheological characteristics are concerned, the results outline different structures of the products: Hylaform® behaves as a strong hydrogel, Restylane® as a weak hydrogel; rheologically Hylaform® is clearly superior to Restylane®. Hylaform® contains a definitely minor quantity (about a quarter) of cross-linked hyaluronic acid than Restylane®. Furthermore, although not declared by the manufacturer, Restylane® contains protein, resulting from bacterial fermentation or added to enable cross-linking reaction; the quantity of proteins contained by Restylane® can be as much as four times the quantity contained by Hylaform®, for the same volume (1 ml). It is evident that Hylaform® offers higher safety margin than Restylane®. Furthermore, wide literature and 20 years of clinical experience on hyaluronan derived from rooster combs confirm the reliability of this derivative while we did not find evidence regarding about the safety of HA obtained from streptococcus.

AB - Hyaluronic acid (HA) derivatives have been developed to try to enhance rheological properties of this molecule to make it suitable for various medical applications. The main dermatological application of HA derivatives is the augmentation of soft tissues, via injection into the dermis. HA derivatives are indicated for the correction of cutaneous contour deficiencies of the skin, particularly in cases of ageing or degenerative lesions or to increase lips. Two HA derivatives have been evaluated: Hylaform® Viscoelastic Gel (Hylan B), derived from rooster combs and subjected to cross-linking, and Restylane®, produced through bacterial fermentation (streptococci) and stabilized, as declared by the producer. In both cases the purpose is to improve HA rheological characteristics and slow down its degradation once it is in contact with biological structures. Distribution of particle dimensions, pH, protein concentration and rheological properties have been investigated in order to evaluate their reliability as fillers for soft tissue augmentation. The results of the analyses showed that there are differences between Restylane® and Hylaform®. Especially as far as rheological characteristics are concerned, the results outline different structures of the products: Hylaform® behaves as a strong hydrogel, Restylane® as a weak hydrogel; rheologically Hylaform® is clearly superior to Restylane®. Hylaform® contains a definitely minor quantity (about a quarter) of cross-linked hyaluronic acid than Restylane®. Furthermore, although not declared by the manufacturer, Restylane® contains protein, resulting from bacterial fermentation or added to enable cross-linking reaction; the quantity of proteins contained by Restylane® can be as much as four times the quantity contained by Hylaform®, for the same volume (1 ml). It is evident that Hylaform® offers higher safety margin than Restylane®. Furthermore, wide literature and 20 years of clinical experience on hyaluronan derived from rooster combs confirm the reliability of this derivative while we did not find evidence regarding about the safety of HA obtained from streptococcus.

KW - Hyaluronic acid

KW - Hylan B

KW - Soft tissue augmentation

UR - http://www.scopus.com/inward/record.url?scp=0032743129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032743129&partnerID=8YFLogxK

U2 - 10.1016/S0926-9959(99)00089-6

DO - 10.1016/S0926-9959(99)00089-6

M3 - Article

C2 - 10642054

AN - SCOPUS:0032743129

VL - 13

SP - 183

EP - 192

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 3

ER -